Estimation of Plasma Folate Apparent Volume of Distribution in Adults

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-06-30

Study Completion Date

2010-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to calculate the plasma apparent volume of distribution of natural folate to give a more accurate value for use in a mathematical model of apparent folate absorption.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Bioavailability of Folate From a Mixed Diet Using a Stable Isotope Method

NCT00130585

Folate Bioavailability Healthy

COMPLETED NA

Effect of Folic Acid on Primary Folate Forms in Relation to MTHFR

NCT01105351

the Effect of MTHFR C677T on Folate Metabolism

COMPLETED NA

Blood Folate and Homocysteine Levels Following Administration of Folic Acid According to Different Daily Dosing Schedules:a Simulation of Food Fortification

NCT00207558

Neural Tube Defects - Spina Bifida and Anencephaly

COMPLETED NA

Increasing Folate Status of a General Population(FOLSUPP STUDY)

NCT00372645

Healthy

COMPLETED NA

Where is the Initial Site of Biotransformation of Folates in Humans?

NCT02135393

Healthy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Bioavailability is a major determinant of nutritional status. In order to determine a safe level of folate fortification, its bioavailability must be assessed, so that risk-benefit analysis can be carried out. Recently, a mathematical model of folate true absorption which takes into account the liver first pass was devised (ref 1). In this model, the volume of distribution is a convenient method for describing how well a nutrient is removed from plasma and distributed into tissues.

In this study, volume of distribution will be more accurately estimated using an intravenous dose of labelled (13C5) dose of natural folate (5-methyltetrahydrofolic acid) in healthy adults aged 18-65, over a wide body mass index (BMI) range.

Healthy adults will be given an IV dose of a small amount of 13C5 5-methyltetrahydrofolic acid, and blood samples will be taken at regular time points via a cannula over a 2hr time period.

The primary objective is to estimate the sampled plasma pool volume of distribution in order to quantify the fraction of any folate test dose, or folate metabolites, appearing in systemic plasma circulation in future studies of bioavailability.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IV dose of 5-methyltetrahydrofolic acid

IV test dose of 13C5-labelled 5-methyltetrahydrofolic acid to all eligible volunteers, followed by regular blood samplings over 2hr period taken via a cannula.

Group Type EXPERIMENTAL

13C5-labelled 5-methyltetrahydrofolic acid

Intervention Type DIETARY_SUPPLEMENT

one intravenous bolus dose of no more than 500nmole 13C5-labelled 5-methyltetrahydrofolic acid, followed by multiple blood samplings at regular time intervals. Total 2hr "intervention".

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

13C5-labelled 5-methyltetrahydrofolic acid

one intravenous bolus dose of no more than 500nmole 13C5-labelled 5-methyltetrahydrofolic acid, followed by multiple blood samplings at regular time intervals. Total 2hr "intervention".

Intervention Type DIETARY_SUPPLEMENT

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

13C5-labelled 5 methyltetrahydrofolic acid, calcium salt 6S-5-CH3-H4-Pte[13C5] Glu-Ca

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males and females
* Aged 18-65
* Body mass index above 19.5 and below 40
* Smokers and non-smokers
* Participation in the FolGene study

Exclusion Criteria

* Pregnancy or been pregnant in last 12 months
* History of fits, seizures or blackouts
* Parallel participation in other research projects which invole dietary intervention and/or sampling of biological fluids/material which study nurses advice would affect either wellbeing of volunteer or the study data, apart from participation in the FolGene study
* Any person related to or living with a member of the study team
* Participation in another research project which involves blood sampling within the last 4 months unless total amount blood combined from both studies is less than 470ml
* Had donated blood within 16 weeks of starting the study
* Prescribed medication for epilepsy/seizures
* Diabetics
* History of any gastrointestinal disorder requiring medical treatment
* Any long term medical condition requiring active treatment which may affect volunteers wellbeing or the study data

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes